We have a track record in conducting clinical research.
We present our scientific findings at meetings.
Our academic research helps improve lives and strengthens scientific insights.
Why more caution is needed in administering QT prolonging drugs to type 1 diabetic patients. 3rd March 2021. 400,000 people are currently living with type 1 diabetes in the UK, one of the highest rates in the world.…
For over a decade, our research has focused on identifying patients at risk of Sudden Cardiac Death (SCD), with a specific emphasis on those with diabetes.…
Considering the risk of QTc prolongation in patients with diabetes mellitus. View publication. Effect of hyperglycaemia in combination with moxifloxacin on cardiac repolarization in male and female patients with type I diabetes. View publication.…
Current studies. 12.061: Type I diabetes monitoring and QTc interval. Diabetes mellitus (DM) is a common metabolic disorder characterised by high blood glucose. It is caused by a lack of pancreatic beta-cell insulin production in type 1 DM.…
Jorg Taubel’s. research examines the effects of cardiac ion channel-blocking drugs on ventricular repolarization delay in healthy individuals and those with diabetes type I and type II. Dr.…
Considering the risk of QTc prolongation in patients with diabetes mellitus. Lorem ipsum dolor sit amet, consectetur adipiscing elit. Suspendisse varius enim in eros elementum tristique.…
Scientific Lead - Cardiac Health, Diabetes. Dr Jorg Taubel is an expert in clinical pharmacology with a special interest in cardiac repolarisation changes related to iatrogenic interference with glucostasis.…
Considering the risk of QTc prolongation in patients with diabetes mellitus. Cardiac. Lorem ipsum dolor sit amet, consectetur adipiscing elit. Suspendisse varius enim in eros elementum tristique.…
Diabetes: Dr Jorg Taubel. Sex: Professor Giuseppe Rosano. Electrocardiography: Dr Boaz Mendzelevski. Hypertension Methodology: Appointment pending. Clinical Trial Design and Methodology. Dr Ulrike Lorch. Hepatology. Professor Kevin Moore.…
He is president-elect of the Heart Failure Association (HFA), Chairman of the Education Committee of the HFA and Chairman of the Study Group on Diabetes and Hypertension of the HFA.…
We have a track record in conducting clinical research.
We present our scientific findings at meetings.
Our academic research helps improve lives and strengthens scientific insights.